1997
DOI: 10.1073/pnas.94.18.9920
|View full text |Cite
|
Sign up to set email alerts
|

Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos

Abstract: Proximal spinal muscular atrophy is an autosomal recessive human disease of spinal motor neurons leading to muscular weakness with onset predominantly in infancy and childhood. With an estimated heterozygote frequency of 1͞40 it is the most common monogenic disorder lethal to infants; milder forms represent the second most common pediatric neuromuscular disorder. Two candidate genes-survival motor neuron (SMN) and neuronal apoptosis inhibitory protein have been identified on chromosome 5q13 by positional cloni… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

13
424
3
4

Year Published

1998
1998
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 602 publications
(444 citation statements)
references
References 31 publications
(59 reference statements)
13
424
3
4
Order By: Relevance
“…Complete loss of Smn function results in early embryonic lethality in mice (Schrank et al, 1997); animals that carry low-copy SMN2 transgenes survive embryogenesis but die postnatally, yet those with high-copy transgenes are completely viable (Hsieh-Li et al, 2000;Monani et al, 2000). Thus, SMA can be viewed as a "protein-dosage" disease, an interpretation that correlates well with the fact that SMA severity is inversely proportional to SMN protein levels (Coovert et al, 1997;Lefebvre et al, 1997).…”
Section: Introductionmentioning
confidence: 76%
See 1 more Smart Citation
“…Complete loss of Smn function results in early embryonic lethality in mice (Schrank et al, 1997); animals that carry low-copy SMN2 transgenes survive embryogenesis but die postnatally, yet those with high-copy transgenes are completely viable (Hsieh-Li et al, 2000;Monani et al, 2000). Thus, SMA can be viewed as a "protein-dosage" disease, an interpretation that correlates well with the fact that SMA severity is inversely proportional to SMN protein levels (Coovert et al, 1997;Lefebvre et al, 1997).…”
Section: Introductionmentioning
confidence: 76%
“…To date, several Smn and Gemin2 alleles have been characterized. Null mutations in mouse Smn and Gemin2 are also early embryonic lethals (Schrank et al, 1997;Jablonka et al, 2002). Expression of a low-copy human SMN2 transgene rescues the embryonic lethality, but the mice die shortly after birth and display severe motor neuron degeneration and muscular atrophy phenotypes (Monani et al, 2000).…”
Section: Gemin3 Smn and Neuromuscular Functionmentioning
confidence: 99%
“…In 1995, the genetic basis of SMA was shown to be due to mutations or deletions of the Survival Motor Neuron 1 ( SMN1 ) gene 2. The encoded protein, termed SMN, is ubiquitous and complete knock out is embryonic lethal 3. Consistent with this, SMA is not a disease of complete absence of the SMN protein but rather due to the low basal levels of SMN produced by a second nearly identical copy of SMN1 , termed the SMN2 gene 4…”
Section: Spinal Muscular Atrophy As a Multi‐organ Disordermentioning
confidence: 99%
“…18 SMA is a common neuromuscular disorder, recognized as the most prevalent genetic cause of early childhood mortality. 19 Clinically, SMA patients show progressive muscle weakness of proximal muscle groups, ultimately leading to paralysis; death is typically caused by progressive and restrictive respiratory failure.…”
Section: Cajal Bodies and Their Componentsmentioning
confidence: 99%